Updated inserter for the 75 mcg Travoprost intracameral implant

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, in-use study follows adults who receive the 75 mcg Travoprost intracameral implant administered with the updated G2-TRIO inserter. Procedures are performed at a Glaukos investigative site in Kenosha, Wisconsin, and data are collected during routine care. Study staff will document inserter performance, procedural success, and any adverse events during and after implantation. There is no randomization or experimental treatment beyond using the updated inserter in standard clinical practice.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of Open-angle glaucoma
* 18 years of age or older

Exclusion Criteria:

* Subject who is breast-feeding or pregnant

Where it's running

• Glaukos Investigative Site
  Kenosha, Wisconsin, United States Recruiting

Study contacts

• Study coordinator: Study Director
• Email: ClinicalResearch@glaukos.com
• Phone: 949-739-8749

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

  In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

  Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

• iDose TR implant administration in an office-based eye clinic

  This study tests a travoprost implant (iDose TR) given inside the eye to people with open-angle glaucoma or high eye pressure in an office setting to see if it is safe.

  Recruiting Glaukos Corporation · Austin, Texas · NCT07816692

• Brillouin hydration mapping to study cornea health

  Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07780890

• Is a preservative-free Bimatoprost 0.01% as effective and safe as Lumigan in POAG or ocular hypertension?

  This study tests whether a preservative-free Bimatoprost 0.01% (YSBP) works as well as Lumigan 0.01% for people with POAG or ocular hypertension.

  Recruiting Phase 3 YS Life Science Co., Ltd. · Beverly Hills, California and 21 other locations · NCT07661329

• Direct (non-contact) laser versus standard selective laser for treating glaucoma

  This test compares a newer non-contact laser (DSLT) with the standard SLT to see if it lowers eye pressure just as well in adults with open-angle glaucoma or ocular hypertension.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07408154

• Cataract surgery with iStent inject versus Kahook Dual Blade goniotomy for open-angle glaucoma

  This trial tests whether adding either two iStent inject implants or a Kahook Dual Blade goniotomy at the time of cataract surgery helps people with open-angle glaucoma lower eye pressure or reduce glaucoma medications.

  Recruiting at 2 sites Medical University of Bialystok · Bialystok, Polska and 1 other locations · NCT07325552

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.